Systems biology based miRNA-mRNA expression pattern analysis of Emodin in breast cancer cell lines.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 30 03 2023
revised: 20 07 2023
accepted: 21 08 2023
medline: 12 9 2023
pubmed: 27 8 2023
entrez: 26 8 2023
Statut: ppublish

Résumé

Breast cancer has been among the most prominent cancers with high mortality. Currently most of the offered therapeutics are toxic; hence, less toxic therapeutic intervention is required. Here, we studied the molecular mechanisms of the effect of a phytoestrogen Emodin on estrogen receptor positive MCF-7 and negative MDA-MB-231 cells by carrying out a comprehensive network assessment. Differentially expressed microRNAs along with their previously identified differentially expressed mRNAs were analyzed through microarrays by using integrative systems biology approach. For each cell line miRNA-target gene networks were built, gene ontology and pathway enrichment analyses were performed, enrichment maps were constructed and the potential key genes, miRNAs and miRNA-gene interactions were studied.

Identifiants

pubmed: 37633004
pii: S0344-0338(23)00480-6
doi: 10.1016/j.prp.2023.154780
pii:
doi:

Substances chimiques

MicroRNAs 0
Emodin KA46RNI6HN
RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154780

Informations de copyright

Copyright © 2023. Published by Elsevier GmbH.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All of the authors have approved the contents of this paper and have agreed to the ‘Pathology - Research and Practice’ submission policies. Furthermore, each named author has substantially contributed to conducting the underlying research and they have no conflict of interest, financial or otherwise. The authors declare there are no conflicts of interest.

Auteurs

Elif Sakalli-Tecim (E)

Department of Biotechnology, Middle East Technical University, Ankara, Turkiye.

Bala Gur-Dedeoglu (B)

Biotechnology Institute, Ankara University, Ankara, Turkiye.

N Tulin Guray (NT)

Department of Biotechnology, Middle East Technical University, Ankara, Turkiye; Department of Biological Sciences, Middle East Technical University, Ankara, Turkiye. Electronic address: guray@metu.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH